BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2001
View Archived Issues
Inspire reports progress for two ophthalmic products at ARVO
Read More
Cell Genesys discusses highlights for the first quarter of 2001
Read More
ARVO 2001 presentations underline promise of squalamine in angiogenic eye diseases
Read More
Merger of BioChem Pharma and Shire to close this week
Read More
Ajinomoto's novel nucleoside analogue exerts therapeutically useful antiherpesvirus activity
Read More
Topical dapsone to be studied for new indication: atopic dermatitis
Read More
MGI's lead acylfulvene advances to phase II for refractory sarcoma
Read More
Phase I/II results reported for ADA in patients with advanced AIDS
Read More
BPI-derived compounds show promise for Rx of pathological retinal neovascularization
Read More
TLK-16998: a nonpeptide IR sensitizer effective in mouse models of type 2 diabetes
Read More
Enzon begins patient treatment in phase I trial of PEG-paclitaxel
Read More
U. of Maryland prepared to begin clinical testing of Multikine for cervical cancer
Read More
Potency of several retinoids assessed in bladder cancer cell lines
Read More
Lilly's duloxetine reduces symptoms of depression in clinical trials
Read More
Abbott presents novel cinnamide-based LFA-1/ICAM-1 antagonist with improved PK properties
Read More
Aventis warns of potential liver injury on Arava
Read More
Orally active Raf kinase inhibitor from Onyx/Bayer in phase I clinical trials
Read More
Avant's oral cholera vaccine shows safety and efficacy in phase IIb trial
Read More
Four Amgen products under regulatory review
Read More
Large number of D4 antagonists synthesized at Aventis
Read More
Eisai presents new acetylcholinesterase-inhibitory piperidines
Read More
New series from Ajinomoto with utility in inflammation, cancer, etc.
Read More
SB-263831 and related compounds act as caspase inhibitors
Read More
Human papillomavirus vaccine patented by Active Biotech
Read More
Metastasis-associated antigen discovered at German center
Read More